Benitec Biopharma earnings were -$22.0M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest BNTC earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$7.4M, up 45.4% from last quarter. For the last reported fiscal year 2024 ending Jun 30, 2024, BNTC reported annual earnings of -$22.4M, with 14.4% growth. The next BNTC earnings date is May 12, 2025.
What were Benitec Biopharma's earnings last quarter?
On BNTC's earnings call on Invalid Date, Benitec Biopharma (NASDAQ: BNTC) reported Q4 2024 earnings per share (EPS) of -$0.00, up 88.46% year over year. Total BNTC earnings for the quarter were -$7.36 million. In the same quarter last year, Benitec Biopharma's earnings per share (EPS) was -$0.03.
The next BNTC earnings call is Invalid Date. Add BNTC to your watchlist to be reminded of Benitec Biopharma's next earnings date.
What was BNTC's earnings growth in the past year?
As of Benitec Biopharma's earnings date in Invalid Date, Benitec Biopharma's earnings has grown year over year. BNTC earnings in the past year totalled -$22.03 million.
Is Benitec Biopharma profitable or losing money?
As of the last Benitec Biopharma earnings report, Benitec Biopharma is currently losing money. Benitec Biopharma's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$21.42 million, a 1.81% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.